RecruitingPhase 3ACTRN12611000401954

Does using progesterone reduce the miscarriage rate in high risk pregnancies?

In pregnant women with previous subfertility, does progesterone supplementation decrease the likelihood of miscarriage?


Sponsor

Dr Luke McLindon

Enrollment

344 participants

Start Date

Jan 20, 2012

Study Type

Interventional

Conditions

Summary

This project will assess the effect of progesterone therapy on pregnancy outcomes in women previously diagnosed with subfertility. It is hypothesised that progesterone supplementation in early pregnancy decreases the likelihood of miscarriage, and potentially late pregnancy complications in women with previous subfertility.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Inclusion Criteria2

  • Previously diagnosed with subfertility (no pregnancy after 12 months random unprotected intercourse, a history of 3 or more miscarriages, failing to achieve an ongoing pregnancy after 12 months of random unprotected intercourse)
  • Pregnancy less than 7 weeks + 0 days

Exclusion Criteria1

  • Women who are pregnant as a result of Assisted Reproductive Technologies

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Progesterone pessary 400 mg, nightly until 12 weeks and 0 days, must be recruited prior to 7 weeks.

Progesterone pessary 400 mg, nightly until 12 weeks and 0 days, must be recruited prior to 7 weeks.


Locations(1)

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000401954


Related Trials